GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Cyclically Adjusted PB Ratio

GSK (GSK) Cyclically Adjusted PB Ratio : 6.99 (As of Apr. 27, 2024)


View and export this data going back to 1987. Start your Free Trial

What is GSK Cyclically Adjusted PB Ratio?

As of today (2024-04-27), GSK's current share price is $41.11. GSK's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $5.88. GSK's Cyclically Adjusted PB Ratio for today is 6.99.

The historical rank and industry rank for GSK's Cyclically Adjusted PB Ratio or its related term are showing as below:

GSK' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.88   Med: 8.05   Max: 12
Current: 7.19

During the past years, GSK's highest Cyclically Adjusted PB Ratio was 12.00. The lowest was 5.88. And the median was 8.05.

GSK's Cyclically Adjusted PB Ratio is ranked worse than
90.88% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs GSK: 7.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GSK's adjusted book value per share data for the three months ended in Dec. 2023 was $8.330. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.88 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GSK's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted PB Ratio Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.57 8.29 8.76 6.76 6.31

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.76 6.59 6.21 6.55 6.31

Competitive Comparison of GSK's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted PB Ratio falls into.



GSK Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GSK's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=41.11/5.88
=6.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, GSK's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.33/130.0000*130.0000
=8.330

Current CPI (Dec. 2023) = 130.0000.

GSK Quarterly Data

Book Value per Share CPI Adj_Book
201403 5.707 99.300 7.471
201406 5.387 99.800 7.017
201409 4.234 100.000 5.504
201412 3.429 99.900 4.462
201503 5.709 99.600 7.452
201506 5.457 100.100 7.087
201509 4.306 100.200 5.587
201512 3.930 100.400 5.089
201603 2.053 100.400 2.658
201606 0.418 101.000 0.538
201609 0.093 101.500 0.119
201612 0.714 102.200 0.908
201703 1.083 102.700 1.371
201706 0.528 103.500 0.663
201709 0.882 104.300 1.099
201712 -0.046 105.000 -0.057
201803 -0.049 105.100 -0.061
201806 2.466 105.900 3.027
201809 2.974 106.600 3.627
201812 2.410 107.100 2.925
201903 2.673 107.000 3.248
201906 2.296 107.900 2.766
201909 7.301 108.400 8.756
201912 7.489 108.500 8.973
202003 8.142 108.600 9.746
202006 8.477 108.800 10.129
202009 9.221 109.200 10.977
202012 9.745 109.400 11.580
202103 10.246 109.700 12.142
202106 10.715 111.400 12.504
202109 10.528 112.400 12.177
202112 9.947 114.700 11.274
202203 10.596 116.500 11.824
202206 9.916 120.500 10.698
202209 5.096 122.300 5.417
202212 6.306 125.300 6.543
202303 7.080 126.800 7.259
202306 7.826 129.400 7.862
202309 8.015 130.100 8.009
202312 8.330 130.000 8.330

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (NYSE:GSK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GSK Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (GSK) Business Description

Industry
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (GSK) Headlines

From GuruFocus

Top 5 3rd Quarter Trades of Parallax Volatility Advisers, L.P.

By GuruFocus Research GuruFocus Editor 11-22-2022

Signature Wealth Management Group Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-10-2023

Ridgewood Investments LLC Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-20-2023